Ventyx Biosciences Inc Cash Flow-to-Debt Ratio
Ventyx Biosciences Inc cash flow-to-debt ratio. Ventyx Biosciences Inc (VTYX) has a Cash Flow-to-Debt Ratio of -0.87x as of September 2025, meaning its operating cash flow of $-17.51 Million could theoretically repay -1% of its total liabilities ($20.10 Million) in one year. See Ventyx Biosciences Inc financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Ventyx Biosciences Inc (2019–2024)
Cash flow-to-debt ratio of Ventyx Biosciences Inc from 2019 to 2024. Historical debt coverage capacity for Ventyx Biosciences Inc across 6 annual periods. Also explore Ventyx Biosciences Inc equity growth rate to track the company's year-over-year net asset growth rate.
Ventyx Biosciences Inc Cash Flow-to-Debt Ratio by Year (2019–2024)
Ventyx Biosciences Inc cash flow-to-debt ratio by year from 2019 to 2024. Year-by-year debt coverage analysis for Ventyx Biosciences Inc. For the full cash flow conversion analysis, see cash flow conversion of Ventyx Biosciences Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -5.81x | $-130.87 Million | $22.52 Million | ▼ -17.9% |
| 2023 | -4.93x | $-166.52 Million | $33.77 Million | ▲ +12.6% |
| 2022 | -5.64x | $-98.77 Million | $17.50 Million | ▼ -79.3% |
| 2021 | -3.15x | $-38.65 Million | $12.28 Million | ▼ -1469.5% |
| 2020 | -0.20x | $-6.20 Million | $30.90 Million | ▲ +66.0% |
| 2019 | -0.59x | $-2.64 Million | $4.48 Million | — |